We are live on ! Find out more
CRVO icon

CervoMed

14 hedge funds and large institutions have $1.77M invested in CervoMed in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

7% less funds holding

Funds holding: 1514 (-1)

16% less capital invested

Capital invested by funds: $2.1M → $1.77M (-$330K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q2 2018 in Review

14 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2018, worth a combined $1.77M — down 16% from $2.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CRVO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $34.3K. The largest seller was Swift Run Capital Management, cutting an estimated $49.7K.

  • 14 institutional investors held CervoMed (CRVO) as of Q2 2018, down from 15 in Q1 2018.
  • Funds reported $1.77M of CervoMed stock for Q2 2018, down 16% quarter-over-quarter.
  • 2 funds opened new CervoMed positions in Q2 2018 and 3 closed out, a net change of -1 holder.
  • The largest CervoMed buyer in Q2 2018 was Renaissance Technologies, an estimated $34.3K added.
  • The largest CervoMed seller in Q2 2018 was Swift Run Capital Management, an estimated $49.7K sold.

Based on aggregated 13F filings for Q2 2018.